… in mortality from lung cancer. Lung cancer remains one of the major causes of cancer-related
death … The most common form of lung cancer is non–small cell lung cancer (NSCLC). …

… The purpose of this study was to assess the role of PET with 18 F-FDG in … 18 F-FDG PET
in the evaluation of adrenal masses detected on CT or MR imaging of patients with lung cancer…

… on various FDG PET/CT-derived parameters of lung cancer … 18 F-FDG PET/CT predicted
a higher risk of recurrence or death in surgical NSCLC patients. Our findings suggest that FDG …

… We included patients with proven lung cancer as well as patients in whom lung cancer …
lung cancer were confirmed. This broad patient spectrum is the population referred for 18 F-FDG …

… ESMO guidelines for non-small-cell lung cancer (NSCLC) consider 18F-FDG PET/CT mandatory
… of 18F-FDG PET/CT in treatment response evaluation and the restaging of lung cancer. …

… 18 F-FDG PET for the assessment of chemotherapy response in patients with non–small cell
lung cancer. … Methods: In 51 patients, dynamic 18 F-FDG PET was performed before and at 5…

… In conclusion, the mechanism of 18 F-FDG accumulation within lung cancer cells is
determined by glucose metabolism, hypoxia, angiogenesis and mTOR signaling pathway. In AC …

… role of 18 F-FDG PET/CT metabolic parameters in stage I lung adenocarcinoma patients. …
Our main finding was the significant correlation between 18 F-FDG PET/CT parameters (SUV …

… PET using 18 F-FDG is a promising technique to monitor … 18 F-FDG PET scans were
obtained on 2 groups of patients. First, 10 patients with advanced non–small cell lung cancer (…

… PET/CT with 18 F-FDG is widely accepted as the diagnostic standard of care. The purpose
… compare a dedicated pulmonary 18 F-FDG PET/MR imaging protocol with 18 F-FDG PET/CT …